What are the major opportunities in the Respiratory Disease Vaccine market? What are the strategies for the Respiratory Disease Vaccine market?

For detailed insights on the major opportunities and strategies in the Respiratory Disease Vaccine market, Read More

How does the Respiratory Disease Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Respiratory Disease Vaccine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Respiratory Disease Vaccine market growth? SWOT analysis of the Respiratory Disease Vaccine market.

For detailed insights on the key dynamics influencing the Respiratory Disease Vaccine market growth and SWOT analysis of the Respiratory Disease Vaccine industry, Read More

Respiratory Disease Vaccine Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Respiratory Disease Vaccine Market Report 2026

Name: Respiratory Disease Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections), By Age (Infant, Adolescent, Adult), By End-User (Clinic, Hospital, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Respiratory Disease Vaccine Market Overview

• Respiratory Disease Vaccine market size has reached to $70.03 billion in 2025

• Expected to grow to $81 billion in 2030 at a compound annual growth rate (CAGR) of 3.2%

• Growth Driver: The Rising Incidence Of Tuberculosis Fueling Market Growth Due To Increased Infection Burden And Escalating Public Health Risks

• Market Trend: Major Players Strive For An Improved Solution Enhancing Efficacy And Prevention

• Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Respiratory Disease Vaccine Market?

Respiratory diseases refer to a wide range of conditions that affect the airways and lungs, leading to respiratory symptoms and impaired breathing. Respiratory disease vaccine refers to a type of vaccine that is an immunization designed to protect individuals from respiratory infections caused by viruses or bacteria that primarily affect the respiratory system, which includes the lungs and airways. These vaccines work by stimulating the immune system to produce antibodies that can recognize and fight the specific pathogen that causes the disease.

The main types of respiratory disease vaccines are viral vaccines, bacterial vaccines and combination vaccines. A viral vaccine is a preparation containing weakened or inactivated viruses that stimulate immune responses and are used to prevent respiratory diseases by training the immune system to recognize and defend against specific viruses, reducing infection spread and severity. They are used in treating infections such as COVID-19, influenza, respiratory syncytial virus (RSV), pneumonia and others in infants, adolescents and adult-aged individuals in clinics, hospitals and others.

Respiratory Disease Vaccine Market Global Report 2026 Market Report bar graph

What Is The Respiratory Disease Vaccine Market Size and Share 2026?

The respiratory disease vaccine market size has grown marginally in recent years. It will grow from $70.03 billion in 2025 to $71.36 billion in 2026 at a compound annual growth rate (CAGR) of 1.9%. The growth in the historic period can be attributed to high prevalence of respiratory infections, limited availability of effective vaccines, government immunization initiatives, advancements in monoclonal antibody research, rising awareness about respiratory health.

What Is The Respiratory Disease Vaccine Market Growth Forecast?

The respiratory disease vaccine market size is expected to see steady growth in the next few years. It will grow to $81 billion in 2030 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to increasing demand for universal vaccines, technological advances in mRNA and viral vector vaccines, expansion of cold-chain infrastructure, growth in public-private partnerships for vaccine distribution, focus on pandemic preparedness and rapid response. Major trends in the forecast period include development of next-generation respiratory vaccines, increased focus on pediatric and geriatric immunization, expansion of immunization programs in emerging markets, rise of combination vaccines for multi-pathogen protection, adoption of rapid vaccine development and distribution platforms.

Book your 30 minutes free consultation with our research experts

Global Respiratory Disease Vaccine Market Segmentation

1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine

2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections

3) By Age: Infant, Adolescent, Adult

4) By End-User: Clinic, Hospital, Other End-Users

Subsegments:

1) By Viral Vaccine: Influenza Vaccine, Respiratory Syncytial Virus (RSV) Vaccine, Coronavirus Vaccine

2) By Bacterial Vaccine: Pneumococcal Vaccine, Haemophilus Influenzae Type B (Hib) Vaccine, Pertussis Vaccine

3) By Combination Vaccine: DTaP With Hib And IPV, Pneumococcal Conjugate Vaccine With Influenza Vaccine

What Is The Driver Of The Respiratory Disease Vaccine Market?

The rising incidence of tuberculosis (TB) is expected to propel the growth of the respiratory disease vaccine market going forward. Tuberculosis is an infectious respiratory illness caused by Mycobacterium tuberculosis, primarily affecting the lungs and representing a significant global health threat. The rise in TB cases is driven by factors such as weakened healthcare systems, delays in diagnosis, and broader transmission patterns, all of which contribute to increased disease burden. Respiratory disease vaccines play a crucial role in mitigating TB-related risks by reducing infection rates, limiting transmission, and supporting global prevention strategies. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 casesTherefore, the rising incidence of tuberculosis is driving the growth of the respiratory disease vaccine industry.

Key Players In The Global Respiratory Disease Vaccine Market

Major companies operating in the respiratory disease vaccine market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Biological E. Limited, CanSino Biologics Inc., Bharat Biotech International Limited, Medicago Inc, CureVac N.V., Incepta Vaccine Ltd, Inovio Pharmaceuticals Inc., Ology Bioservices, VBI Vaccines Inc.

Global Respiratory Disease Vaccine Market Trends and Insights

Major companies operating in the respiratory disease vaccine market are concentrating on creating innovative products to enhance their efficacy and provide improved solutions for preventing and treating respiratory disease infections. For instance, in May 2023, Pfizer Inc., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval for ABRYSVO (Respiratory Syncytial Virus Vaccine), the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. ABRYSVO is an unadjuvanted vaccine made up of a pair of preF proteins tailored to maximize immunity to RSV A and B varieties and it has been clinically proven to be safe and productive.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Respiratory Disease Vaccine Market?

In February 2024 AstraZeneca Plc a UK-based biopharmaceutical company, acquired Icosavax, Inc for an undisclosed amount. With this acquisition, AstraZeneca aims to enhance its vaccine development capabilities and expand its pipeline of next-generation immunotherapies. Icosavax Inc is a US-based biotechnology company that specializes in developing virus-like particle (VLP) vaccines targeting infectious diseases.

Regional Insights

Asia-Pacific was the largest region in the respiratory disease vaccine market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Respiratory Disease Vaccine Market?

The respiratory diseases vaccine market consists of sales of the rotavirus vaccine, bordetella vaccine and varicella (chickenpox) vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Respiratory Disease Vaccine Market Report 2026?

The respiratory disease vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Respiratory Disease Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$71.36 billion
Revenue Forecast In 2035	$81 billion
Growth Rate	CAGR of 1.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Infection, Age, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc.,
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Respiratory Disease Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Respiratory Disease Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Respiratory Disease Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Respiratory Disease Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Development of Next-Generation Respiratory Vaccines

4.2.2 Increased Focus on Pediatric and Geriatric Immunization

4.2.3 Expansion of Immunization Programs in Emerging Markets

4.2.4 Rise of Combination Vaccines for Multi-Pathogen Protection

4.2.5 Adoption of Rapid Vaccine Development and Distribution Platforms

5. Respiratory Disease Vaccine Market Analysis Of End Use Industries

5.1 Clinics

5.2 Hospitals

5.3 Government Immunization Centers

5.4 Pharmaceutical Companies

5.5 Research Laboratories

6. Respiratory Disease Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Respiratory Disease Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Respiratory Disease Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Respiratory Disease Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Respiratory Disease Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Respiratory Disease Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Respiratory Disease Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Respiratory Disease Vaccine Market Segmentation

9.1. Global Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vaccine, Bacterial Vaccine, Combination Vaccine

9.2. Global Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections

9.3. Global Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infant, Adolescent, Adult

9.4. Global Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinic, Hospital, Other End-Users

9.5. Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Influenza Vaccine, Respiratory Syncytial Virus (RSV) Vaccine, Coronavirus Vaccine

9.6. Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pneumococcal Vaccine, Haemophilus Influenzae Type B (Hib) Vaccine, Pertussis Vaccine

9.7. Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Combination Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DTaP With Hib And IPV, Pneumococcal Conjugate Vaccine With Influenza Vaccine

10. Respiratory Disease Vaccine Market Regional And Country Analysis

10.1. Global Respiratory Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Respiratory Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Respiratory Disease Vaccine Market

11.1. Asia-Pacific Respiratory Disease Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Respiratory Disease Vaccine Market

12.1. China Respiratory Disease Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Respiratory Disease Vaccine Market

13.1. India Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Respiratory Disease Vaccine Market

14.1. Japan Respiratory Disease Vaccine Market Overview

14.2. Japan Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Respiratory Disease Vaccine Market

15.1. Australia Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Respiratory Disease Vaccine Market

16.1. Indonesia Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Respiratory Disease Vaccine Market

17.1. South Korea Respiratory Disease Vaccine Market Overview

17.2. South Korea Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Respiratory Disease Vaccine Market

18.1. Taiwan Respiratory Disease Vaccine Market Overview

18.2. Taiwan Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Respiratory Disease Vaccine Market

19.1. South East Asia Respiratory Disease Vaccine Market Overview

19.2. South East Asia Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Respiratory Disease Vaccine Market

20.1. Western Europe Respiratory Disease Vaccine Market Overview

20.2. Western Europe Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Respiratory Disease Vaccine Market

21.1. UK Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Respiratory Disease Vaccine Market

22.1. Germany Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Respiratory Disease Vaccine Market

23.1. France Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Respiratory Disease Vaccine Market

24.1. Italy Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Respiratory Disease Vaccine Market

25.1. Spain Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Respiratory Disease Vaccine Market

26.1. Eastern Europe Respiratory Disease Vaccine Market Overview

26.2. Eastern Europe Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Respiratory Disease Vaccine Market

27.1. Russia Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Respiratory Disease Vaccine Market

28.1. North America Respiratory Disease Vaccine Market Overview

28.2. North America Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Respiratory Disease Vaccine Market

29.1. USA Respiratory Disease Vaccine Market Overview

29.2. USA Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Respiratory Disease Vaccine Market

30.1. Canada Respiratory Disease Vaccine Market Overview

30.2. Canada Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Respiratory Disease Vaccine Market

31.1. South America Respiratory Disease Vaccine Market Overview

31.2. South America Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Respiratory Disease Vaccine Market

32.1. Brazil Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Respiratory Disease Vaccine Market

33.1. Middle East Respiratory Disease Vaccine Market Overview

33.2. Middle East Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Respiratory Disease Vaccine Market

34.1. Africa Respiratory Disease Vaccine Market Overview

34.2. Africa Respiratory Disease Vaccine Market, Segmentation By Type, Segmentation By Infection, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Respiratory Disease Vaccine Market Regulatory and Investment Landscape

36. Respiratory Disease Vaccine Market Competitive Landscape And Company Profiles

36.1. Respiratory Disease Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Respiratory Disease Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Respiratory Disease Vaccine Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

37. Respiratory Disease Vaccine Market Other Major And Innovative Companies

GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S

38. Global Respiratory Disease Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Respiratory Disease Vaccine Market

40. Respiratory Disease Vaccine Market High Potential Countries, Segments and Strategies

40.1 Respiratory Disease Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Respiratory Disease Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Respiratory Disease Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Respiratory Disease Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global Respiratory Disease Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Respiratory Disease Vaccine Market, Supply Chain Analysis

Table 4: Global Respiratory Disease Vaccine Market, Major Raw Material Providers

Table 5: Global Respiratory Disease Vaccine Market, Major Resource Providers

Table 6: Global Respiratory Disease Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global Respiratory Disease Vaccine Market, Major Distributors And Channel Partners

Table 8: Global Respiratory Disease Vaccine Market, Key Technologies & Future Trends

Table 9: Global Respiratory Disease Vaccine Market, Major Trends

Table 10: Global Respiratory Disease Vaccine Market, Major End Users

Table 11: Global Respiratory Disease Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Respiratory Disease Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Respiratory Disease Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Respiratory Disease Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Combination Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Respiratory Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Respiratory Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Respiratory Disease Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Respiratory Disease Vaccine Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Johnson & Johnson Ltd. Financial Performance

Table 100: Merck & Co. Inc. Financial Performance

Table 101: Sanofi SA Financial Performance

Table 102: AstraZeneca PLC Financial Performance

Table 103: Global Respiratory Disease Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Respiratory Disease Vaccine Market, Competitive Dashboard

Table 105: Global Respiratory Disease Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Respiratory Disease Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Respiratory Disease Vaccine Market Size Gain ($ Billion), Segmentation By Infection, 2025 – 2030

Table 108: Global, Respiratory Disease Vaccine Market Size Gain ($ Billion), Segmentation By Age, 2025 – 2030

List Of Figures

Figure 1: Global Respiratory Disease Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global Respiratory Disease Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Respiratory Disease Vaccine Market, Supply Chain Analysis

Figure 4: Global Respiratory Disease Vaccine Market, Major Raw Material Providers

Figure 5: Global Respiratory Disease Vaccine Market, Major Resource Providers

Figure 6: Global Respiratory Disease Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global Respiratory Disease Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global Respiratory Disease Vaccine Market, Key Technologies & Future Trends

Figure 9: Global Respiratory Disease Vaccine Market, Major Trends

Figure 10: Global Respiratory Disease Vaccine Market, Major End Users

Figure 11: Global Respiratory Disease Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Respiratory Disease Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Respiratory Disease Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Respiratory Disease Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Respiratory Disease Vaccine Market, Sub-Segmentation Of Combination Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Respiratory Disease Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Respiratory Disease Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Respiratory Disease Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Respiratory Disease Vaccine Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Johnson & Johnson Ltd. Financial Performance

Figure 100: Merck & Co. Inc. Financial Performance

Figure 101: Sanofi SA Financial Performance

Figure 102: AstraZeneca PLC Financial Performance

Figure 103: Global Respiratory Disease Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Respiratory Disease Vaccine Market, Competitive Dashboard

Figure 105: Global Respiratory Disease Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Respiratory Disease Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Respiratory Disease Vaccine Market Size Gain ($ Billion), Segmentation By Infection, 2025 – 2030

Figure 108: Global, Respiratory Disease Vaccine Market Size Gain ($ Billion), Segmentation By Age, 2025 – 2030

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Influenza Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric,...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Conjugate Vaccine Market Report 2026 - Global Outlook – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meni...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Travel Vaccines Market Report 2026 - Global Outlook – By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By ...

Adult Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Con...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Frequently Asked Questions

How big is the Respiratory Disease Vaccine Market?

The Respiratory Disease Vaccine market was valued at $70.03 billion in 2025, increased to $71.36 billion in 2026, and is projected to reach $81 billion by 2030.

What is the Respiratory Disease Vaccine market growth?

The global Respiratory Disease Vaccine market is expected to grow at a CAGR of 3.2% from 2026 to 2035 to reach $81 billion by 2035.

Who are the key players in Respiratory Disease Vaccine market?

Some Key Players in the Respiratory Disease Vaccine market Include, Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Biological E. Limited, CanSino Biologics Inc., Bharat Biotech International Limited, Medicago Inc, CureVac N.V., Incepta Vaccine Ltd, Inovio Pharmaceuticals Inc., Ology Bioservices, VBI Vaccines Inc. .

What is the anticipated growth trend for the Respiratory Disease Vaccine market?

Major trend in this market includes: Major Players Strive For An Improved Solution Enhancing Efficacy And Prevention. For further insights on this market. request a sample here

Which region has the most growth potential in the Respiratory Disease Vaccine market?

Asia-Pacific was the largest region in the respiratory disease vaccine market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory disease vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.